- Home
- SQFTP vs OCEAW Comparison
SQFTP vs OCEAW Comparison
Compare SQFTP & OCEAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SQFTP
- OCEAW
- Stock Information
- Founded
- SQFTP N/A
- OCEAW N/A
- Country
- SQFTP United States
- OCEAW United States
- Employees
- SQFTP 15
- OCEAW 7
- Industry
- SQFTP Real Estate Investment Trusts
- OCEAW Biotechnology: Pharmaceutical Preparations
- Sector
- SQFTP Real Estate
- OCEAW Health Care
- Exchange
- SQFTP Nasdaq
- OCEAW Nasdaq
- Market Cap
- SQFTP N/A
- OCEAW N/A
- IPO Year
- SQFTP N/A
- OCEAW 2021
- Fundamental
- Price
- SQFTP $15.28
- OCEAW $0.03
- Analyst Decision
- SQFTP
- OCEAW
- Analyst Count
- SQFTP 0
- OCEAW 0
- Target Price
- SQFTP N/A
- OCEAW N/A
- AVG Volume (30 Days)
- SQFTP N/A
- OCEAW N/A
- Earning Date
- SQFTP N/A
- OCEAW N/A
- Dividend Yield
- SQFTP N/A
- OCEAW N/A
- EPS Growth
- SQFTP N/A
- OCEAW N/A
- EPS
- SQFTP N/A
- OCEAW N/A
- Revenue
- SQFTP N/A
- OCEAW N/A
- Revenue This Year
- SQFTP N/A
- OCEAW N/A
- Revenue Next Year
- SQFTP N/A
- OCEAW N/A
- P/E Ratio
- SQFTP N/A
- OCEAW N/A
- Revenue Growth
- SQFTP N/A
- OCEAW N/A
- 52 Week Low
- SQFTP N/A
- OCEAW N/A
- 52 Week High
- SQFTP N/A
- OCEAW N/A
- Technical
- Relative Strength Index (RSI)
- SQFTP 51.03
- OCEAW N/A
- Support Level
- SQFTP $14.76
- OCEAW N/A
- Resistance Level
- SQFTP $15.50
- OCEAW N/A
- Average True Range (ATR)
- SQFTP 0.28
- OCEAW 0.00
- MACD
- SQFTP -0.05
- OCEAW 0.00
- Stochastic Oscillator
- SQFTP 60.42
- OCEAW 0.00
About SQFTP Presidio Property Trust Inc. 9.375% Series D Cumulative Redeemable Perpetual Preferred Stock $0.01 par value per share
Presidio Property Trust Inc is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. The office, industrial and retail properties are located primarily in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California.
About OCEAW Ocean Biomediacal Inc.
Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.